Welcome to the New Cell Transplant and Regenerative Medicine Society

The Cell Transplant Society is thrilled to outline some new changes to our Society that were annouced during the recent 2015 IPITA-IXA-CTS Joint Congress in Melbourne, Australia.

The first and most exciting announcement was made during recent strategic planning sessions for the Society; the CTS Council has approved a name change for the Society to become the "Cell Transplant and Regenerative Medicine Society." This new Society name better describes the membership of our interdisciplinary group, and will broaden our scientific focus to include research and researchers in the growing and exciting field of regenerative medicine. In the coming months you will see our website, social media and 2017 Congress announcements reflecting this change and utilizing our new logo as shown below.

ctrms logo

The CTRMS Council has also adopted a new mission statement to reflect the expanded goals of our Society. The new mission is:

"The Cell Transplant and Regenerative Medicine Society exists to be the leader in developing and translating, safe cellular and regenerative therapies to patients. The Society will promote research, collaboration and focus on regulatory matters, as they relate to clinical translation."

We look forward to updating the membership on the ongoing activities of the Society throughout 2016.

CTRMS 2017 Congress - Halifax, Nova Scotia, Canada

The location for the next Cell Transplant and Regenerative Medicine Society meeting will be in the beautiful city of Halifax, Nova Scotia, Canada from September 26-29th of 2017! This meeting will be held for the first time in partnership with the Canadian Society of Transplantation. Please save the date, and stay tuned to the website and/or social media outlets for exciting new developments about the upcoming Congress.

Cell Transplant Postcard DRAFT V6 1Cell Transplant Postcard DRAFT V6 2

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi